145 related articles for article (PubMed ID: 23440398)
41. CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis.
Sugaya M; Morimura S; Suga H; Kawaguchi M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
J Dermatol; 2015 Jun; 42(6):613-5. PubMed ID: 25809616
[TBL] [Abstract][Full Text] [Related]
42. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.
Peternel S; Prpić-Massari L; Manestar-Blažić T; Brajac I; Kaštelan M
Arch Dermatol Res; 2011 Aug; 303(6):389-97. PubMed ID: 21279373
[TBL] [Abstract][Full Text] [Related]
44. The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris.
Kanda N; Tani K; Enomoto U; Nakai K; Watanabe S
Clin Exp Allergy; 2002 Aug; 32(8):1243-50. PubMed ID: 12190666
[TBL] [Abstract][Full Text] [Related]
45. Neuropeptides in the skin of patients with atopic dermatitis.
Ostlere LS; Cowen T; Rustin MH
Clin Exp Dermatol; 1995 Nov; 20(6):462-7. PubMed ID: 8857337
[TBL] [Abstract][Full Text] [Related]
46. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
47. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
48. [Expression of TWEAK and Its Receptor CD163 in Peripheral Blood of Psoriasis Vulgaris (PV)].
Yang BC; Li MM; Deng XQ; Cao NN; Guo ZP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Sep; 49(5):720-724. PubMed ID: 30378333
[TBL] [Abstract][Full Text] [Related]
49. Correlation between serum IL-16 and atopic dermatitis.
Zheng HY; Zhao L; Li CX; Li SH
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050978
[TBL] [Abstract][Full Text] [Related]
50. Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis.
Scarponi C; Nardelli B; Lafleur DW; Moore PA; Madonna S; De Pità O; Girolomoni G; Albanesi C
J Interferon Cytokine Res; 2006 Mar; 26(3):133-40. PubMed ID: 16542135
[TBL] [Abstract][Full Text] [Related]
51. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis.
Mashiko S; Mehta H; Bissonnette R; Sarfati M
J Dermatol Sci; 2017 Nov; 88(2):167-174. PubMed ID: 28743611
[TBL] [Abstract][Full Text] [Related]
52. Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1.
Wang Y; Zhang Y; Peng G; Han X
Int Immunopharmacol; 2018 Jul; 60():9-17. PubMed ID: 29702284
[TBL] [Abstract][Full Text] [Related]
53. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
[TBL] [Abstract][Full Text] [Related]
54. High mobility group box 1 protein (HMGB1) as biomarker in hypoxia-induced persistent pulmonary hypertension of the newborn: a clinical and
Tang Z; Jiang M; Ou-Yang Z; Wu H; Dong S; Hei M
Int J Med Sci; 2019; 16(8):1123-1131. PubMed ID: 31523175
[No Abstract] [Full Text] [Related]
55. miRNA expression profiles of the perilesional skin of atopic dermatitis and psoriasis patients are highly similar.
Carreras-Badosa G; Maslovskaja J; Vaher H; Pajusaar L; Annilo T; Lättekivi F; Hübenthal M; Rodriguez E; Weidinger S; Kingo K; Rebane A
Sci Rep; 2022 Dec; 12(1):22645. PubMed ID: 36587063
[TBL] [Abstract][Full Text] [Related]
56. Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis.
Uchida T; Suto H; Ra C; Ogawa H; Kobata T; Okumura K
Int Immunol; 2002 Dec; 14(12):1431-8. PubMed ID: 12456591
[TBL] [Abstract][Full Text] [Related]
57. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive skin biomarkers quantification of psoriasis and atopic dermatitis: cytokines, antioxidants and psoriatic skin auto-fluorescence.
Portugal-Cohen M; Horev L; Ruffer C; Schlippe G; Voss W; Ma'or Z; Oron M; Soroka Y; Frušić-Zlotkin M; Milner Y; Kohen R
Biomed Pharmacother; 2012 Jun; 66(4):293-9. PubMed ID: 22397760
[TBL] [Abstract][Full Text] [Related]
59. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.
Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T
Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535
[TBL] [Abstract][Full Text] [Related]
60. Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris.
Bayramgürler D; Ozkara SK; Apaydin R; Erçin C; Bilen N
J Cutan Pathol; 2004 Oct; 31(9):586-94. PubMed ID: 15330989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
